A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

NCT00666900 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

366

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Low Strength IDP-107
DRUG: High Strength IDP-107
DRUG: Placebo Comparator

Sponsor

Dow Pharmaceutical Sciences